Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
McDonald's
MCD
|
+$376M |
| 2 |
Apple
AAPL
|
+$264M |
| 3 |
STJ
St Jude Medical
STJ
|
+$263M |
| 4 |
Microsoft
MSFT
|
+$260M |
| 5 |
Alibaba
BABA
|
+$172M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 2 |
CAM
CAMERON INTERNATIONAL CORPORATION
CAM
|
+$261M |
| 3 |
Gilead Sciences
GILD
|
+$247M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$232M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$214M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.56% |
| 2 | Healthcare | 4.73% |
| 3 | Financials | 4.3% |
| 4 | Consumer Discretionary | 3.31% |
| 5 | Energy | 2.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Infosys
INFY
$51B
| $50.7M | 0.07% |
5,682,310
-116,204
| -2% | -$1.09M |
|
252
CALL
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$259M
| $50.6M | 0.07% |
4
+1
| +33% | +$18.1M |
|
|
MON
253
PUT
DELISTED
Monsanto Co
MON
| $50.5M | 0.07% |
488,400
+375,700
| +333% | +$37.2M |
|
254
Franklin Resources
BEN
$16.8B
| $50.1M | 0.07% |
1,501,422
+674,515
| +82% | +$24.5M |
|
|
HOLX
255
DELISTED
Hologic
HOLX
| $49.8M | 0.06% |
1,440,471
+1,061,459
| +280% | +$36.8M |
|
256
PUT
Walmart Inc
WMT
$909B
| $49.8M | 0.06% |
2,047,200
+592,800
| +41% | +$13.7M |
|
257
Eli Lilly
LLY
$1.08T
| $49.7M | 0.06% |
631,078
+12,685
| +2% | +$955K |
|
258
PUT
General Motors
GM
$80.9B
| $49.5M | 0.06% |
1,749,500
+747,100
| +75% | +$22.7M |
|
259
CALL
Bausch Health
BHC
$1.75B
| $49.5M | 0.06% |
2,457,700
+1,309,700
| +114% | +$37.1M |
|
260
CALL
Johnson & Johnson
JNJ
$640B
| $49.5M | 0.06% |
407,800
+35,200
| +9% | +$4M |
|
261
Kraft Heinz
KHC
$32.8B
| $49.3M | 0.06% |
557,725
+3,196
| +0.6% | +$263K |
|
262
Ventas
VTR
$47.5B
| $49.3M | 0.06% |
677,243
+43,210
| +7% | +$2.85M |
|
263
PUT
Medtronic
MDT
$112B
| $49.1M | 0.06% |
565,670
+243,900
| +76% | +$19.7M |
|
264
Zimmer Biomet
ZBH
$18.8B
| $49M | 0.06% |
419,660
-189,287
| -31% | -$21.4M |
|
265
Prologis
PLD
$136B
| $48M | 0.06% |
979,086
+412,534
| +73% | +$19.4M |
|
|
PPL
266
PPL Corp
PPL
$26.9B
| $47.1M | 0.06% |
1,248,467
+94,497
| +8% | +$3.6M |
|
267
Eastman Chemical
EMN
$7.69B
| $47M | 0.06% |
692,805
+482,556
| +230% | +$35.5M |
|
268
PUT
Texas Instruments
TXN
$248B
| $46.9M | 0.06% |
749,100
+462,900
| +162% | +$27.5M |
|
269
NXP Semiconductors
NXPI
$60.8B
| $46.8M | 0.06% |
597,983
+182,187
| +44% | +$15.6M |
|
|
B
270
PUT
Barrick Mining
B
$60.9B
| $46.4M | 0.06% |
2,174,000
+1,883,300
| +648% | +$33.5M |
|
271
Intercontinental Exchange
ICE
$87.2B
| $46.3M | 0.06% |
905,265
+640,680
| +242% | +$32.3M |
|
272
CALL
Agnico Eagle Mines
AEM
$72.2B
| $45.9M | 0.06% |
858,200
+94,600
| +12% | +$4.3M |
|
273
Starbucks
SBUX
$119B
| $45.8M | 0.06% |
801,150
+208,231
| +35% | +$11.8M |
|
274
CALL
Procter & Gamble
PG
$340B
| $45.4M | 0.06% |
536,300
+133,700
| +33% | +$11M |
|
|
CELG
275
DELISTED
Celgene Corp
CELG
| $45.4M | 0.06% |
460,363
-69,476
| -13% | -$7.19M |
|
Similar funds
Barclays's Q2 2016 Portfolio in Review
As of Q2 2016, Barclays held 7,054 positions worth $76.9B, up 17% from $65.6B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Barclays deployed $9.16B of net new capital in Q2 2016, opening 709 new positions and adding to 2,754 existing holdings. Its largest new stake was S&P Global: 236,625 shares worth $25.4M.
By sector, the portfolio is most concentrated in Technology at 5.6% of assets, up from 5.5% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $995M trimmed.
- Barclays's largest Q2 2016 buy was S&P Global: 236,625 shares worth $25.4M.
- Barclays added most to McDonald's in Q2 2016, an estimated $376M increase.
- Barclays's biggest Q2 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $995M.
- Barclays fully exited CAMERON INTERNATIONAL CORPORATION in Q2 2016, selling an estimated $261M.
- Barclays's ten largest holdings make up 32% of its $76.9B portfolio in Q2 2016.
- Barclays opened 709 new positions and closed 569 in Q2 2016.
- Barclays's portfolio value rose 17% quarter-over-quarter to $76.9B.
Based on Barclays's 13F filing for Q2 2016, filed 12 Aug 2016.